Weight fluctuation was associated with increased risk for cardiovascular disease and mortality among individuals with type 1 diabetes.

According to Soleno Therapeutics, the FDA required more time to review responses to recent information requests. The FDA has extended the review period for the NDA for DCCR tablets for the treatment ...

Asian American, Native Hawaiian, and Pacific Islander (AANHPI) patients with early-stage hepatocellular carcinoma (HCC) have significantly better survival outcomes compared with non-Hispanic White ...

Infertility services accessibility remained inequitable among non-White patients, especially among those without private insurance.

Exposure to elexacaftor-tezacaftor-ivacaftor (ETI) is associated with metabolic syndrome (MetSyn) in patients with cystic fibrosis.